AI MARKET SCANNING

Iovance Biotherapeutics Inc.

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -0.70%
MAX GAP RECORD -27.65%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $IOVA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (UNDETERMINED)
+0.00%
May 07, 2026 Earnings Release 2026-05-07 (BEFORE OPEN)
-14.18%
Feb 24, 2026 Earnings Release 2026-02-24 (UNDETERMINED)
+0.00%
Nov 06, 2025 Earnings Release 2025-11-06 (BEFORE OPEN)
+24.86%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
-27.65%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
+1.60%
Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN)
+0.78%
Nov 07, 2024 Earnings Release 2024-11-07 (AFTER CLOSE)
-13.11%

VOLATILITY & GAP BIAS

AVG GAP MOVE 8.9%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $IOVA

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗